CLOCK通过乙化PRPS1/2促进质母细胞细胞的增殖
Juanjuan Liu1, Zhaoyuan Meng2, Runze Wang1
1Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao Cancer Institute, School of Basic Medicine of Qingdao University, Qingdao, 266000, China.
Journal of neuro-oncology
|July 19, 2025
概括
皮表皮生长因子 (EGF) 激活了一条涉及CK2,CLOCK和PRPS1/2的途径,破坏昼夜节律并促进质母细胞瘤 (GBM) 的生长. 这种EGFR-CLOCK-PRPS1/2轴与侵袭性瘤和患者生存率低下有关.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 时间生物学 时间生物学
背景情况:
- 循环时钟功能障碍与癌症的发展有关.
- 皮表皮生长因子受体 (EGFR) 的激活对于质母细胞瘤 (GBM) 发病过程至关重要.
- 在GBM中,EGFR信号与生理时钟调节之间的联系在很大程度上仍未被探索.
研究的目的:
- 调查EGFR激活是否影响GBM的昼夜时钟.
- 阐明EGFR信号通过昼夜钟影响GBM瘤发生的分子机制.
- 在EGFR-CLOCK-PRPS1/2轴内识别潜在的治疗点.
主要方法:
- 利用分子生物学技术,包括DNA突变,qPCR,免疫沉和免疫光.
- 产生了CLOCK和PRPS1/2突变体,并使用了shRNA用于基因沉默.
- 评估了GBM细胞的增殖和迁移,并分析了GBM标本中的蛋白质表达和局部化.
主要成果:
- EGF刺激导致S106的CK2介导的CLOCK酸化,破坏了CLOCK-BMAL1结合和昼夜基因表达.
- 酸化的CLOCK被从核中输出,导致PRPS1/2.2.的细胞酸性乙化.
- 这种乙化稳定了PRPS1/2,增强了GBM细胞的增殖和迁移;高水平的CLOCK pS106,PRPS1/2 K29ac和PRPS1/2与晚期瘤阶段和低生存率相关.
结论:
- EGFR激活通过通过CLOCK酸化和随后的PRPS1/2乙化来破坏昼夜节律,促进GBM的进展.
- 已确定的EGFR-CLOCK-PRPS1/2轴代表了GBM中一种新的致癌途径.
- 临床发现表明,CLOCK pS106,PRPS1/2 K29ac和PRPS1/2是侵略性GBM和不良预后的潜在生物标志物.
更多相关视频
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
36.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


